ÍøºìºÚÁÏ

Skip to main content

Biljana Horn, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Biljana Horn

Research at a glance

Top areas of exploration

  • Hematopoietic Stem Cell Transplantation , 34 publications
  • Graft vs Host Disease , 12 publications
  • Transplantation Conditioning , 11 publications
  • Transplantation, Homologous , 10 publications

Research activity

60 publications

1,620 citations

Why is this important?

Active clinical trials

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
1 Year - 70 Years
Sexes
All
Conditioning SCID Infants Diagnosed Early (CSIDE)

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
0 Years - 2 Years
Sexes
All

My publications

60 publications

2012

Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial.

Evidence-based complementary and alternative medicine : eCAM

•

2012

Massage for children undergoing hematopoietic cell transplantation: a qualitative report.

Evidence-based complementary and alternative medicine : eCAM

•

2011

Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

•

2010

Clinical update on graft-versus-host disease in children.

Seminars in cutaneous medicine and surgery

•

2010

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.

Journal of neuro-oncology

•